期刊文献+

OPN、B7-H4在上皮性卵巢癌患者血清中的表达及临床意义 被引量:1

Clinical significance and expression of OPN and B7-H4 in serum of patients with epithelial ovarian cancer
下载PDF
导出
摘要 目的观察骨桥蛋白(OPN)、B7-H4在上皮性卵巢癌患者血清中的表达,并探讨其对肿瘤良恶性的鉴别价值。方法选取2013年2月至2015年12月在我院接受治疗的100例上皮性卵巢癌患者为观察对象,同时选取100例卵巢良性肿瘤的患者、100例健康成年女性为对照。观察不同组别OPN、B7-H4及肿瘤标志物水平的差异,比较不同临床病理特征的患者OPN、B7-H4水平的差异。结果上皮性卵巢癌组的OPN、B7-H4阳性表达率高于卵巢良性肿瘤组和健康对照组;3组血清CEA、CA15-3和CA125水平由高到低分别为上皮性卵巢癌组、卵巢良性肿瘤组和健康对照组,差异具有统计学意义(P<0.05);Ⅲ+Ⅳ期、低分化、有淋巴结转移的上皮性卵巢癌患者的OPN、B7-H4表达率较高,差异具有统计学意义(P<0.05),而不同年龄的患者其OPN、B7-H4表达率差异无统计学意义(P>0.05)。结论 OPN、B7-H4在上皮性卵巢癌中高表达,且低分化、转移的患者其OPN、B7-H4阳性表达率更高。 Objective To observe the expression of osteopontin(OPN) and B7-H4 in epithelial ovarian cancer, and to explore the differential diagnosis of benign and malignant value. Methods A total of 100 patients with epithelial ovarian cancer who were treated in our hospital from February 2013 to December 2015 were selected as the study subjects, 100 patients with benign ovarian tumor and 100 healthy controls were selected as the control groups. The differences of OPN, B7-H4 and tumor marker levels in different groups were observed, and the differences of OPN and B7-H4 levels in patients with different clinical pathological characteristics were compared. Results The positive expression rate of OPN and B7-H4 in epithelial ovarian cancer group was higher than those in benign ovarian tumor group and healthy control group. The levels of CEA,CA15-3 and CA125 in serum of the three groups from high to low were epithelial ovarian cancer group,benign ovar- ian tumor group and healthy control group, the differences were statistically significant (P 〈 0.05). Stage III and IV,low differentiation, lymph node metastasis of epithelial ovarian cancer patients of OPN and BT-H4 expression rate was higher, and the difference was statistically signifi- cant ( P 〈 0.05). The expression rate of OPN and B7-H4 in different age patients had no significant difference (P 〉 0.05). Conclusion B7- H4 and OPN are highly expressed in epithelial ovarian cancer,and the expression rate of OPN and B7-H4 is higher in the patients with low differentiation and metastasis.
出处 《局解手术学杂志》 2016年第12期867-870,共4页 Journal of Regional Anatomy and Operative Surgery
关键词 卵巢癌 骨桥蛋白 B7-H4 恶性 良性 ovarian cancer osteopontin B7-H4 malignant benign
  • 相关文献

参考文献10

二级参考文献109

  • 1沈杨,任慕兰,蔡云朗,刘毅.端粒酶活性检测联合血清CA_(125)检测在卵巢肿瘤诊断中的临床意义[J].东南大学学报(医学版),2004,23(4):244-245. 被引量:1
  • 2李孟达,李玉洁,黄永文,黄鹤.影响上皮性卵巢癌远期疗效的因素分析[J].癌症,2004,23(11):1306-1310. 被引量:19
  • 3程燕,宁刚,宋彬,朱慧莉,赵福敏,鲍莉,罗小华.卵巢癌术后复发及腹膜转移的多排螺旋CT表现及其与血清CA125的关系[J].四川大学学报(医学版),2007,38(4):736-738. 被引量:7
  • 4章华础,萧祥熊.组织多肽特异性抗原检测及其临床应用(文献综述)[J].放射免疫学杂志,2007,20(4):339-342. 被引量:7
  • 5Ozols RF,Bookman MA, Connolly DC, et al. Focus on epithelial ovarian cancer[J]. Cancer Cell, 2004,5 (1) : 19-24.
  • 6Hellstrom I, Raycraft J, Hayden-ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J].Cancer Res,2003,63(?) :3695- 3700.
  • 7Kamei M,Yamashita SI,Tokuishi K,et al. HFA expression can be asso ciated with lymph node metastases and disease-free survival in breast cancer[J]. Anticancer Research, 2010,30 (11) :4779- 4783.
  • 8Coppola D,Szabo M,Boulware D,et al. Correlation of osteopontin pro- tein expression and pathological stage across a wide variety of tumor histologies[J]. Clin Cancer Res,2004,10(1) :184-190.
  • 9Drapkin R,Horsten HH, LinY,et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by se- rous and endometrioid ovarian carcinomas[J].Cancer Res,2005, 65(3):2162-2169.
  • 10Pan HW,Ou YH,Peng SY, et al. Overexpression of osteopontin is associated with intrahepatie metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma [J]. Cancer, 2003,98 ( 1 ) : 119.

共引文献149

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部